Emma has 25 years of experience leading, advising, and growing businesses at the intersection of technology, financial services and capital markets across the Asia Pacific, the US, the UK and EMEA.

She has in-depth knowledge of various operating models, data and technology environments, and diverse cultural settings, working in 30 countries and serving on a wide range of boards. Emma’s executive career includes over 16 years in the US-based market as a Nasdaq technology leader and as Group CEO and Managing Director of an ASX-listed company in the global payments technology and open banking arena.

Emma’s expertise includes strategy formulation, leveraging technology and partnerships, new ventures, mergers and acquisitions integration, and complex regulatory and stakeholder engagement. She has led and advised highly regulated market infrastructure operators and disruptive companies across technology, financial, industrial and healthcare sectors, including collaboration with the American Medical Association’s venture capital arm. Across multiple businesses, Emma has initiated and directed structural, technological and transformational change to drive sustainable growth and value creation.

Emma holds a Bachelor of Arts in Political and Social Sciences and a Graduate Diploma in Applied Finance and Investment. She is an Alumnus of the University of Pennsylvania Wharton School Advance Management Program (AMP) and has undertaken executive studies at Harvard Business School. She is a Graduate and Member of the Australian Institute of Company Directors (GAICD), a Fellow of the Financial Services Institute of Australasia (FINSIA) and a Member of the Professional Risk Managers’ International Association (PRMIA).